Folate
Active ingredient
Sold as Menatrol · Folixate · Livita Children
- Drug class
- -
- Availability
- Prescription only
- Routes
- Oral
- Markets covered
- 1
- Products on record
- 3
- FDA reports (12 mo)
- 2
Overview
Plain-language summary, compiled from the cited regulatory records
Folate is a nutrient that plays a vital role in the body. It is used in dietary management for individuals with specific nutritional requirements who need elevated folate levels and vitamin D supplementation [1]. This formulation is suitable for women of childbearing age, pregnant women, and both lactating and non-lactating mothers [1].
Folate is available under various brand names, including Menatrol, Folixate, and Livita Children [1]. In the past 12 months, there have been 2 adverse event reports associated with folate-containing products [2]. Common reactions reported include arrhythmia, decreased appetite, headache, insomnia, and nausea [2].
This is not medical advice. Consult a qualified healthcare professional.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| US United States | FDA | 3 | December 17, 2024 |
USUnited States· FDA
3 products
Uses
INDICATIONS AND USAGE:
Livita™ liquid is indicated to provide significant amounts of essential vitamins and minerals, including Vitamins A, C, D, E, thiamine, riboflavin, niacin, vitamin B6, vitamin B12, folate, calcium, magnesium, and zinc, to supplement the diet.
This comprehensive nutrient profile helps prevent nutritional deficiencies of these vitamins and minerals, ensuring that the specific dietary needs of adults and children are met to support overall health, energy, and vitality. The product is specially formulated to target common vitamin and mineral gaps in adults, thus promoting optimal health, immune function, bone strength, and metabolic balance.
It is intended to be used under the guidance of a licensed healthcare practitioner to ensure that any potential for nutritional deficiency is addressed in a manner that supports the individual's overall health and wellbeing.
Sources & citations
- [1]FDA DailyMed · 0ca12bbf-0b00-34… · revised December 17, 2024 [PDF]
- [2]OpenFDA adverse-event reports (US), 12 months ending June 4, 2026.
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.